Increasingly, life science companies are applying omics-based testing to clinical trials. These tests support precision medicine models for the study of rare cancers and other diseases. Genomics research tests, for example, can help account for diverse drug responses and outcomes caused by genetic differences in trial participants.
The volume, variety, and velocity of data being collected in clinical trials is constantly increasing. It regularly surpasses what any one person or even a team of people can process, organize and monitor. Companies can no longer throw people at the problem, which is why many have turned to automation and AI to fill the gap.
Now that we’ve reached the end of the year, Egnyte is excited to share some new gifts in the form of releases for Egnyte for Life Sciences, Secure and Governance, and the Desktop App. Check out some of the top releases for December below.